← All trials

NCT90000002

Phase 3Interventional

Phase 3

View on ClinicalTrials.gov ↗

Timeline

Start date
Apr 1, 2019
Primary completion
Nov 1, 2021
Completion date
Jan 1, 2022
First posted
Mar 1, 2019
Last posted
Feb 1, 2022
Enrollment
400
Arms / groups
2 / 2
Source
ClinicalTrials.gov · AACT

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.